NCT06218303 2026-03-12
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ
University of Pittsburgh
Phase 1 Recruiting
Clinical Trials
12 trialsNCT04144023 2026-03-05
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
Mayo Clinic
Phase 1 Recruiting
NCT07408856 2026-02-13
CAN1012 in OED, DCIS, and LCIS.
Providence Health & Services
Phase 1 Not yet recruiting
NCT05340673 2026-01-28
Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
City of Hope Medical Center
Phase 1 Active not recruiting
NCT07178665 2025-11-14
Pilot Trial of Preop Partial Radiation in Breast Cancer Patients
Rutgers, The State University of New Jersey
Phase 1 Suspended
NCT01009437 2017-12-05
Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00788112 2017-08-07
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
University of California, San Francisco
Phase 1 Completed
NCT00005886 2017-01-13
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer
University of Kansas Medical Center
Phase 1 Completed
NCT01372644 2016-12-05
Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial
NYU Langone Health
Phase 1 Completed
NCT00107211 2014-09-17
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00290732 2013-10-31
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Completed
NCT00749437 2012-06-14
Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer
Rutgers, The State University of New Jersey
Phase 1 Completed